Shasqi
PrivateLast Round
Grant
Dec 8, 2021
Est. Valuation
$1.79M
Total Funding Raised
$64.03M
Company Overview
Shasqi operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in December 2021.
Shasqi is a biotechnology company that develops cancer therapeutics using its proprietary CAPAC (Click Activated Protodrugs Against Cancer) platform, which utilizes in vivo click chemistry for targeted drug delivery to tumor sites to enhance efficacy and minimize systemic toxicity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shasqi Comparables
Compare Shasqi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tagworks Pharmaceuticals | 88% | |
| Avacta Group | 75% | |
| CytomX Therapeutics | 74% |
For institutional investors. Book with your work email.
Shasqi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 8, 2021 | ||||
| Series B | Nov 11, 2021 | ||||
| Grant | Apr 27, 2021 | ||||
| Series A | Oct 31, 2019 | ||||
| Seed | Jul 20, 2016 | ||||
Accelerator | Jan 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Shasqi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Y Combinator | Seed, Accelerator, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 58% MoM.
- Nov 11, 2021
Raised $50M with participation from Bill Rieflin and Juan Jaen.
For institutional investors. Book with your work email.
Shasqi Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shasqi's valuation, stock price, and market status.
Is Shasqi a public or private company?
Shasqi is a private company.
What is the current stock price of Shasqi?
Shasqi is a private company, so its shares have no public market price. Caplight tracks Shasqi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shasqi worth (valuation)?
Shasqi's valuation is estimated at $1.8M based on funding round data.
Can I buy Shasqi stock?
Shasqi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shasqi's last funding round?
Shasqi's most recent funding round was Grant on December 8, 2021.
Who are the main investors in Shasqi?
Key investors in Shasqi include Y Combinator.
Will Shasqi IPO soon?
No public IPO plans have been announced for Shasqi.
How can I track Shasqi secondary market activity?
Caplight tracks bids, offers, and trades in Shasqi's shares on secondary markets.